Skip to main content
. 2017 Jun 19;2017(6):CD010010. doi: 10.1002/14651858.CD010010.pub3

Clancy 1985.

Methods Double‐blind, placebo‐controlled, prospective RCT over a 3‐month winter period in 1983
Participants 50 patients from Royal Newcastle Hospital with COPD not taking corticosteroids or immunosuppressants
Mean age of all participants: 65.5
Interventions NTHi vaccine and 2 placebo arms (enteric‐coated glucose tablets or 25 mg sodium tauroglycocholate). 3 courses of tablets were taken at 0, 28, 56 days. Each course was 2 tablets taken before breakfast on 3 consecutive days.
Outcomes
  1. Number of lower respiratory infections

  2. Haemophilus influenzae isolation

  3. Salivary antibodies

Notes Many participants were taking antibiotics and bronchodilator agents but were not taking steroids or immunosuppressants.
Ciba‐Geigy (Australia) was cited for financial assistance in the Discussion.
Trial was conducted at the Royal Newcastle Hospital.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk Randomisation was completed independently by a "Dr Smith" who kept the trial code allocations privately; how randomisation was performed was not disclosed. Whilst Dr Smith is not one of the trial authors, the exact nature of their relationship with the study is unknown. Randomisation in 1 arm had a very uneven male‐to‐female ratio
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk For each participant with an acute upper and lower respiratory infection, an infection questionnaire was completed by doctors who were not involved with the study and had no knowledge of the participant's test group
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk
  1. Infection questionnaire with an independent doctor with no knowledge of test group

  2. Sputum cultures collected to detect H influenzae involvement objectively

  3. Blood tests collected to assess salivary antibodies objectively

Incomplete outcome data (attrition bias) 
 All outcomes Low risk All participants were accounted for. 2 participants out of the 50 originally enrolled died during the study
Selective reporting (reporting bias) Low risk Nil
Other bias Low risk Nil